Drug Utilization Study for Pirinase Hayfever Relief

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

February 15, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

Aqueous suspension of 0.05% micronised fluticasone propionate.Each actuation contains 50 micrograms of fluticasone propionate

Trial Locations (1)

Unknown

GSK Investigational Site, Brentford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT02856282 - Drug Utilization Study for Pirinase Hayfever Relief | Biotech Hunter | Biotech Hunter